| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |